Improving access to HIV prevention for Black women in New Orleans
Start the conversation: A multi-level PrEP initiative for Black women in NOLA
This study is working to help Black women in New Orleans learn more about PrEP, a medication that can prevent HIV, by creating a friendly social media campaign and providing support to doctors, so everyone feels comfortable talking about and using it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10755298 on NIH RePORTER |
What this research studies
This research aims to reduce HIV infections among Black cisgender women in New Orleans by addressing barriers to PrEP (pre-exposure prophylaxis) uptake. It involves developing a social media campaign to raise awareness and encourage conversations about PrEP among patients, while also creating strategies for healthcare providers to offer PrEP during routine care. The project will include focus groups with Black women to tailor the campaign and ensure it resonates with the community's needs. By engaging both patients and providers, the initiative seeks to create a supportive environment for PrEP adoption.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black cisgender women living in New Orleans who are at risk for HIV.
Not a fit: Patients who are not Black cisgender women or those who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase awareness and access to HIV prevention methods for Black women, ultimately reducing infection rates.
How similar studies have performed: Previous research has shown that targeted awareness campaigns can effectively increase the uptake of preventive health measures in underserved communities.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Corneli, Amy Lynn — Duke University
- Study coordinator: Corneli, Amy Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.